Table 2.
Average acetylcholine efflux (± SEM; pmol/20 μL) during baseline collections. There were no significant differences among the treatment groups.
| Session 1 (High K+/Ca2+) | Session 2 (Galantamine) | |||||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| Group | Baseline 1 | Baseline 2 | Baseline 3 | Baseline 4 | Baseline 1 | Baseline 2 | Baseline 3 | Baseline 4 |
| NC (n) | 0.016 ± 0.004 (7) |
0.012 ± 0.002 (7) |
0.011 ± 0.001(7) |
0.009 ± 0.002 (7) |
0.008 ± 0.003 (5) |
0.009 ± 0.003 (6) |
0.009 ± 0.003 (6) |
0.008 ± 0.002 (6) |
| IC (n) | 0.015 ± 0.002 (6) |
0.016 ± 0.003 (6) |
0.014 ± 0.003 (6) |
0.012 ± 0.002 (6) |
0.006 ± 0.001 (7) |
0.008 ± 0.003 (7) |
0.010 ± 0.003 (6) |
0.010 ± 0.002 (7) |
| ET (n) | 0.008 ± 0.001 (3) |
0.010 ± 0.002 (3) |
0.010 ± 0.002 (3) |
0.010 ± 0.001 (3) |
0.004 ± 0.001 (3) |
0.004 ± 0.001 (3) |
0.005 ± 0.001 (3) |
0.004 ± 0.001 (3) |